Showing results (1-10 of 308) with videos related to
Sort By:
Pageof 31
Thrombosis and Haemostasis|February 4, 2010
Lack of outcome benefit and clopidogrel "resistance." The TRITON trial challengeV SerebruanyCardiology|February 10, 2011
Aspirin dose and ticagrelor benefit in PLATO: fact or fiction?Victor L SerebruanyCardiology|January 8, 2011
Mortality benefit in PLATO cannot be explained by antiplatelet properties of ticagrelorVictor L SerebruanyInternational Journal of Cardiology|July 1, 2015
Redesigning TRACER trial after TRITONVictor L SerebruanyAmerican Journal of Therapeutics|June 18, 2009
Late prasugrel benefit in STEMI patients?Victor L SerebruanyThe American Journal of Medicine|January 31, 2006
Selective serotonin reuptake inhibitors and increased bleeding risk: are we missing something?Victor L SerebruanyExpert Opinion on Pharmacotherapy|December 24, 2005
Argatroban, a direct thrombin inhibitor for heparin-induced thrombocytopaenia: present and future perspectivesMichael V Serebruany, Alex I Malinin, Victor L SerebruanyFundamental & Clinical Pharmacology|June 9, 2009
Aggressive chronic platelet inhibition with prasugrel and increased cancer risks: revising oral antiplatelet regimens?Victor L SerebruanyCardiology|January 25, 2014
Angiographic outcomes contradict platelet data in the PLATO trial: confusion over official trial substudiesVictor L SerebruanyPageof 31